Search Results Search Sort by RelevanceMost Recent Podcast Nov 2008 Ethics Talk: Corporate Wellness Programs Are wellness programs making us sicker? Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary Oct 2003 Drugs for the Shy? Jeremy A. Lazarus, MD Virtual Mentor. 2003;5(10):405-407. doi: 10.1001/virtualmentor.2003.5.10.ccas1-0310. Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311. Policy Forum Aug 2016 Ethical Considerations about EHR-Mediated Results Disclosure and Pathology Information Presented via Patient Portals Kristina A. Davis, MD and Lauren B. Smith, MD An emerging medical ethics issue is whether to delay posting pathology reports to electronic health records (EHR) to allow clinicians time to follow up. AMA J Ethics. 2016;18(8):826-832. doi: 10.1001/journalofethics.2016.18.8.pfor1-1608. State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Sep 2001 Obligations to Noncompliant Patients Faith Lagay, PhD Virtual Mentor. 2001;3(9):289-290. doi: 10.1001/virtualmentor.2001.3.9.hlaw1-0109. State of the Art and Science Jun 2001 Genetic Disparity: Unfair or Only Unfortunate? Faith Lagay, PhD Virtual Mentor. 2001;3(6):187-190. doi: 10.1001/virtualmentor.2001.3.6.gnth1-0106. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary Oct 2003 Drugs for the Shy? Jeremy A. Lazarus, MD Virtual Mentor. 2003;5(10):405-407. doi: 10.1001/virtualmentor.2003.5.10.ccas1-0310.
Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311.
Policy Forum Aug 2016 Ethical Considerations about EHR-Mediated Results Disclosure and Pathology Information Presented via Patient Portals Kristina A. Davis, MD and Lauren B. Smith, MD An emerging medical ethics issue is whether to delay posting pathology reports to electronic health records (EHR) to allow clinicians time to follow up. AMA J Ethics. 2016;18(8):826-832. doi: 10.1001/journalofethics.2016.18.8.pfor1-1608.
State of the Art and Science Jun 2003 Reducing the Effects of Low Health Literacy Faith Lagay, PhD Virtual Mentor. 2003;5(6):222-224. doi: 10.1001/virtualmentor.2003.5.6.cprl1-0306.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Sep 2001 Obligations to Noncompliant Patients Faith Lagay, PhD Virtual Mentor. 2001;3(9):289-290. doi: 10.1001/virtualmentor.2001.3.9.hlaw1-0109.
State of the Art and Science Jun 2001 Genetic Disparity: Unfair or Only Unfortunate? Faith Lagay, PhD Virtual Mentor. 2001;3(6):187-190. doi: 10.1001/virtualmentor.2001.3.6.gnth1-0106.